Physician profile
Didem Inanoglu
NPI 1255324422
$13,465.49
in general payments reported to CMS, 2019-2025
8 companies · $99.00 in 2025
The $99.00 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,780 · 2020: $1,990 · 2021: $4,945 · 2022: $148 · 2023: $248 · 2024: $256 · 2025: $99.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $5,179.97 | 2021-2024 | Xeomin |
| Allergan, INC. | $4,791.39 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $2,495.02 | 2019-2024 | Dysport |
| Merz North America, INC. | $375.75 | 2019 | |
| Piramal Critical Care | $215.51 | 2019-2025 | |
| Medtronic USA, INC. | $197.85 | 2019 | |
| Mdd US Operations, LLC | $151.28 | 2019 | |
| Saol Therapeutics INC. | $58.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Didem Inanoglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.